Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

349 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Durelli L, Verdun E, Barbero P, Bergui M, Versino E, Ghezzi A, Montanari E, Zaffaroni M; Independent Comparison of Interferon (INCOMIN) Trial Study Group. Durelli L, et al. Among authors: zaffaroni m. Lancet. 2002 Apr 27;359(9316):1453-60. doi: 10.1016/s0140-6736(02)08430-1. Lancet. 2002. PMID: 11988242 Clinical Trial.
Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis.
Cosentino M, Zaffaroni M, Marino F, Bombelli R, Ferrari M, Rasini E, Lecchini S, Ghezzi A, Frigo G. Cosentino M, et al. Among authors: zaffaroni m. J Neuroimmunol. 2002 Dec;133(1-2):233-40. doi: 10.1016/s0165-5728(02)00372-7. J Neuroimmunol. 2002. PMID: 12446028
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection?
Cosentino M, Zaffaroni M, Giorelli M, Marino F, Ferrari M, Bombelli R, Rasini E, Trojano M, Lecchini S, Livrea P, Comi G, Frigo G. Cosentino M, et al. Among authors: zaffaroni m. Trends Pharmacol Sci. 2004 Jul;25(7):350-1; author reply 351-2. doi: 10.1016/j.tips.2004.04.010. Trends Pharmacol Sci. 2004. PMID: 15219975 No abstract available.
Immunological patterns identifying disease course and evolution in multiple sclerosis patients.
Furlan R, Rovaris M, Martinelli Boneschi F, Khademi M, Bergami A, Gironi M, Deleidi M, Agosta F, Franciotta D, Scarpini E, Uccelli A, Zaffaroni M, Kurne A, Comi G, Olsson T, Filippi M, Martino G. Furlan R, et al. Among authors: zaffaroni m. J Neuroimmunol. 2005 Aug;165(1-2):192-200. doi: 10.1016/j.jneuroim.2005.04.012. J Neuroimmunol. 2005. PMID: 15949850
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis.
Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Rivoiro C, Ferrero C, Picco E, Ripellino P, Giuliani G, Montanari E, Clerico M; Italian Multiple Sclerosis Study Group. Durelli L, et al. J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. doi: 10.1136/jnnp.2007.130229. Epub 2007 Nov 6. J Neurol Neurosurg Psychiatry. 2008. PMID: 17986500 Clinical Trial.
Female-specific issues in multiple sclerosis.
Ghezzi A, Zaffaroni M. Ghezzi A, et al. Among authors: zaffaroni m. Expert Rev Neurother. 2008 Jun;8(6):969-77. doi: 10.1586/14737175.8.6.969. Expert Rev Neurother. 2008. PMID: 18505361 Review.
349 results